Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bilateral Serratus Intercostal Plane Block for Myocardial Revascularization (SERRINT) (SERRINT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03813225
Recruitment Status : Unknown
Verified August 2019 by Fundación Cardiovascular de Colombia.
Recruitment status was:  Recruiting
First Posted : January 23, 2019
Last Update Posted : August 22, 2019
Sponsor:
Information provided by (Responsible Party):
Fundación Cardiovascular de Colombia

Brief Summary:

Two-parallel arm, double-blind, individually randomized controlled trial.

Primary endpoint:

Fentanyl consumption in the first 48 postoperative hours.

Secondary endpoints:

Pain at rest, Pain on movement, stay in ICU, Postoperative nausea and vomiting (PONV), sedation, Hemothorax, seizures, arrythmias


Condition or disease Intervention/treatment Phase
Pain, Postoperative Pain Management Analgesia, Patient-Controlled Nerve Block Other: Bilateral serratus Intercostal plane Block Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 44 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:

Intervention: BILATERAL SERRATUS INTERCOSTAL- PLANE BLOCK plus usual multimodal analgesia

Control:

Usual multimodal analgesia

Masking: Triple (Participant, Care Provider, Outcomes Assessor)
Masking Description: Participant: The Patients will not know about intervention group they will be. Care Provider : The medical, nursing and pain clinical will not know the group to which the patient belongs Outcomes Assessor: during the analysis the staff will not know which group the patient belong
Primary Purpose: Supportive Care
Official Title: Randomized Clinical Trial to Evaluate the Superiority on the Decrease the Consumption of Fentanyl the First 48 Hours of Bilateral Serratus Intercostal Plane Block in Myocardial Revascularization Surgery by Sternotomy.
Actual Study Start Date : January 15, 2019
Estimated Primary Completion Date : August 30, 2019
Estimated Study Completion Date : September 30, 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
No Intervention: Conventional Analgesia

These patients will receive the protocol multimodal analgesia patients receive on the Colombian Cardiovascular Foundation for handling an analgesic in cardiovascular surgery, this start in surgery with Lidocaine 0.5mcg/k. Dexamethasone 8mcg, Fentanyl Bolus: 7mcg/k . infusion of Fentanyl 4 mcg/k/h start after induction , go down to 2 Mcg/k/h during extracorporeal circulation , after extracorporeal circulation the infusion will be suspended of Fentanyl.

and the postoperative analgesia will be 500mg of acetaminophen oral and Analgesia, patient controlled with Fentanyl 20mcg/bolus.

Experimental: Serrato intercostal plane Block
These patients will receive the protocol multimodal analgesia patients receive on the Colombian Cardiovascular Foundation with Lidocaine 0.5mcg/k. Dexamethasone 8mcg, Fentanyl Bolus: 7mcg/k . infusion of Fentanyl 4 mcg/k/h start after induction , go down to 2 Mcg/k/h during extracorporeal circulation , after extracorporeal circulation the infusion will be suspended of Fentanyl.In this Arm the patient will give a bilateral serratus intercostal plane block, will be performed echo-guided puncture in the line anterior axillar with fifth costal arch, whit 21 ml of anesthetic mass, 20 ml of Levobupivacaine 0.375 and 1 mg (2mg) of dexamethasone. and the postoperative analgesia will be 500mg of acetaminophen oral and Analgesia, patient controlled with Fentanyl 20mcg/bolus
Other: Bilateral serratus Intercostal plane Block
Will be performed by echo guided one puncture in the fifth costal arch with anterior axilary line, where the tip of the needle will be guided until it reaches a point above the external intercostal muscle, below the anterior serratus above the costal arch where they will be administered 21 ml of anesthesic mass, (20 ml of levobupivacaine 0.375 and 1 mg (2mg) of dexamethasone.)




Primary Outcome Measures :
  1. Fentanyl Consume [ Time Frame: 48 hours ]
    Microgrames of Fentanyl that patient consume during the first 48 hours in the postoperative


Secondary Outcome Measures :
  1. Pain In Rest and in motion [ Time Frame: 48 hours ]
    It will be valued the pain at rest and in motion, by means of the verbal analog scale for pain, where zero is the absence of pain and 10 is the worst pain that has had on the lives, the pain is measured from the time of extubation what we will call zero hour, and every four hours per 48 hours.

  2. Nausea and vomiting [ Time Frame: 48 hours. ]
    Presence of nausea and vomiting during the first 48 hours postoperative.

  3. Sedation [ Time Frame: 48 hours. ]
    Assessment of sedation in the first 48 hours postoperative with the Ramsay scale .The Ramsay scale , Is a subjective scale to assess the degree of sedation of patients, values 6 levels, from 1 where the patient is anxious and agitated ,2 Awake, coperador, focused and quiet. 3. Slept with response to orders. 4. Sleepy with brief answers to the Light. 5 is patient Slept with an answer only to the pain and 6 where the patient is deep asleep without response to stimuli.

  4. hemothorax [ Time Frame: 24 hours ]
    presence of hemothorax secundary to blockage

  5. seizures [ Time Frame: 1 hour after block ]
    presence of seizure after to blockage

  6. Arrhythmias [ Time Frame: 1 hour after block ]
    presence of Arrhythmias after of blockage



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patient between 18 years to 80 years
  • Patient to myocardial revascularization by sternotomy

Exclusion Criteria:

  • Patient for combined surgery ( myocardial revascularization by sternotomy plus valve or maze)
  • Emergency surgery
  • Ejection Fraction less than 35%
  • Allergy to the local anesthesics.
  • Allergy to opioids
  • Patient in who will be technically impossible the application of the blockade

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03813225


Contacts
Layout table for location contacts
Contact: Luz Pacheco, Esp 57 7 6396767 ext 411 luzjepal@gmail.com
Contact: Anderson Bernmon, MsC 57 7 6399292 andebermon@gmail.com

Locations
Layout table for location information
Colombia
Luz Jenny Pacheco Recruiting
Floridablanca, Santander, Colombia, 681004
Contact: luz Pacheco, Esp    57 7 6396767 ext 411    luzjepal@gmail.com   
Sponsors and Collaborators
Fundación Cardiovascular de Colombia
Investigators
Layout table for investigator information
Principal Investigator: luz Pacheco, Esp Fundacion Cardiovascular
Layout table for additonal information
Responsible Party: Fundación Cardiovascular de Colombia
ClinicalTrials.gov Identifier: NCT03813225    
Other Study ID Numbers: fcv465
First Posted: January 23, 2019    Key Record Dates
Last Update Posted: August 22, 2019
Last Verified: August 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Fundación Cardiovascular de Colombia:
Analgesia, patient- controlled, Block , Pain Postoperative
Additional relevant MeSH terms:
Layout table for MeSH terms
Pain, Postoperative
Postoperative Complications
Pathologic Processes
Pain
Neurologic Manifestations